Views

Abstract: 968

PDF (English): 430

Cited-by

1. Zhu Z, Jin Y, Zhou J, Chen F, Chen M, Gao Z, et al. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives. Molecular Cancer. 2024;23(1). doi: 10.1186/s12943-024-02059-y
2. Zheng Z. Triptolide induces immunogenic cell death in cervical cancer cells via ER stress and redox modulation. American Journal of Cancer Research. 2025;15(1):69. doi: 10.62347/XNVR3799
3. Wang H, Sun P, Yuan X, Xu Z, Jiang X, Xiao M, et al. Autophagy in tumor immune escape and immunotherapy. Molecular Cancer. 2025;24(1). doi: 10.1186/s12943-025-02277-y
4. Zhang L, Zhang D, Shi J, Huang M, Yu J, Chen X, et al. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products. Phytomedicine. 2024;132:155828. doi: 10.1016/j.phymed.2024.155828
5. Zhang L, Hu H, Cai W, Chen S, Sheng P, Fu X. CaCO3-complexed pH-responsive nanoparticles encapsulating mitoxantrone and celastrol enhance tumor chemoimmunotherapy. International Journal of Pharmaceutics. 2024;667:124860. doi: 10.1016/j.ijpharm.2024.124860